Isomorphic Labs — AI supply-chain exposure

Isomorphic Labs is Alphabet's drug-discovery subsidiary, spun out of Google DeepMind to apply AlphaFold-lineage models — the protein-structure systems that reshaped computational biology — to designing therapeutics. In THE ENTITY's map it sits in the applications layer as a consumer of the stack below it: it integrates GPUs and inference serving and wraps them in agentic scientific workflows rather than building any of that infrastructure itself.

The structural hook is that Isomorphic represents the demand side of the chain — the kind of high-value, science-native application that helps justify the compute build-out. Its leverage comes from proprietary models and biological data plus its parent's access to infrastructure, not from hardware. Because it depends on the layers beneath it, its placement reflects downstream pull on compute rather than any pricing power over it; the value it captures would come from drugs, not from anything it sells into the AI supply chain.